| Typicality: | 0.216 |
| Saliency: | 0.126 |
| in the placebo group | 12 | other |
| in 144 subjects | 12 | other |
| diabetes → be reported as → adverse reaction | 6 |
| negative | neutral | positive |
| 0.667 | 0.319 | 0.014 |
| Raw frequency | 6 |
| Normalized frequency | 0.126 |
| Modifier score | 0.500 |
| Perplexity | 39.344 |